To determine if there are significant differences in clinical outcomes between encephalitis patients of different racial and ethnic backgrounds.
Of the 601 patients, 313 were non-Hispanic White (52.1%) and 288 were of an ethnic minority (47.9%). Ethnic minority patients were significantly younger (median 44 vs 56; p = <.001), with a higher proportion of abnormal electroencephalograms (EEG) compared to non-Hispanic Whites (84% v 72.1%; p = .005). Ethnic minority patients had a higher incidence of autoimmune encephalitis (24% vs 16.7%; p = .042). Non-Hispanic Whites were more likely to present with memory deficits (36.7% vs 26.7%; p = .01). Ethnic minority patients had worse Sequential Organ Failure Assessments (SOFA) (44.2% with SOFA >3 vs 34.4%; p = .025) and Full Outline of UnResponsiveness Scores (FOUR Score) (28.6% with FOUR Score <14 vs 20.4%; p = .026) at presentation. A higher proportion of non-Hispanic Whites had worse outcomes on the Glasgow Outcome Scale (GOS) (76.5% with GOS <5 vs 50.2%; p = <.001), and significantly more ethnic minority patients were alive post-treatment (73.2% vs 44%; p = <.001).
We found significant differences between non-Hispanic White and ethnic minority encephalitis patients in age, EEGs, presenting signs, and patient outcomes. Further work is needed to determine the role of age as a confounding variable in patient outcomes.